ITMCTR2000004017招募中1 期
Effect of Nian-Mo granules for IgA nephropathy by regulating intestinal microecology
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 18 至 80（—）
- 性别
- All
入选标准
- •1. IgA nephropathy was confirmed by renal biopsy;
- •2. The glomerular filtration rate (eGFR) was more than 50 ml / min·1.73 m2;
- •3. Aged >= 18 years and <= 80 years, regardless of gender;
- •4. They agreed to participate in the study and signed informed consent.
排除标准
- •1. Secondary IgAN, such as cirrhosis, lupus nephritis, hepatitis B associated nephritis, purpura nephritis, etc.;
- •2. Those who use steroid or immunosuppressant within 3 months;
- •3. No abnormality was found in stool microscopic examination, and no antibiotics or lactulose drugs affecting fecal pH value were used within 3 months before collecting fecal and blood samples;
- •4. Severe damage of heart, brain and liver function or other serious basic diseases.
研究者
相似试验
招募中
不适用
Effect of Immunosuppression in IgA nephropathyKCT0003039Yonsei University Health System, Severance Hospital172
已完成
1 期
Influence of IgA Nephropathy ? Prescription on Serum Gd-IgA1 and BAFF level for Patients with IgA NephropathyITMCTR2200005824HuQianqian
招募中
不适用
Is The Occurrence of IgA-Nephropathy modulated by Gene Mutations of Phase 1 and 2 Detoxification Enzymes?CKD with particular reference to IgA nephropathyDRKS00012928Förderverein Nephrologie e.V.200
招募中
4 期
Dapagliflozin treatment in IgA nephropathy patientsIgA nephropathyJPRN-jRCT1031220369Tomohito Gohda150
已完成
不适用
Impact of immunosuppressive therapy in IgA nephropathyN03.3DRKS00025167niversitätsklinikum Freiburg131